The effects of progesterone and progestins on endometrial proliferation

被引:34
|
作者
Moyer, DL
Felix, JC
机构
[1] NovaMed Lab, Unit 102, Thousand Oaks, CA 91362 USA
[2] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA USA
[3] Univ So Calif, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA
关键词
progesterone; progestin; hormone replacement therapy; endometrium;
D O I
10.1016/S0010-7824(98)00047-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A total of 99 premenopausal and 27 postmenopausal women were evaluated to determine the quantity of glandular proliferation resulting from progestin inhibition of estrogen-primed subjects and of subjects without hormonal stimulation. Endometrial glandular proliferation rates were determined by using mitosis counts, proliferation-cell nuclear antigen (PCNA), and nuclear cyclin (MIB1) immunocytological staining. The endometria of normally cycling premenopausal women, of women who received a synthetic progestin, and of untreated postmenopausal women were studied. In unheated normally cycling premenopausal women, the proliferation of the glandular epithelium was increased during the follicular phase and decreased during the luteal phase. Premenopausal women receiving a synthetic progestin and untreated postmenopausal women who were not estrogen-primed showed minimal epithelial proliferation. Endometrial glandular proliferation is inhibited by endogenous progesterone in premenopausal women. Endometrial proliferation is markedly reduced in premenopausal women receiving a synthetic progestin and in untreated postmenopausal women. CONTRACEPTION 1998;57:399-403 (C) 1998 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 50 条
  • [21] PROGESTINS IN ADVANCED ENDOMETRIAL CANCER
    MARZI, MM
    PECORELLI, S
    FRANCESCHI, S
    LAVECCHIA, C
    SARTORI, E
    CANCER TREATMENT REPORTS, 1979, 63 (07): : 1200 - 1200
  • [22] HISTOLOGICAL-EVALUATION OF INVITRO RESPONSES OF ENDOMETRIAL ADENOCARCINOMA TO PROGESTINS AND THEIR RELATION TO PROGESTERONE-RECEPTOR LEVELS
    HOLINKA, CF
    DELIGDISCH, L
    GURPIDE, E
    CANCER RESEARCH, 1984, 44 (01) : 293 - 296
  • [23] Progesterone and progestins: neuroprotection and myellin repair
    Schumacher, Michael
    Sitruk-Ware, Regine
    De Nicola, Alejandro F.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (06) : 740 - 746
  • [24] Effects of progestins and relaxin on glycodelin gene expression in human endometrial cells
    Taylor, RN
    Vigne, JL
    Zhang, PL
    Hoang, P
    Lebovic, DI
    Mueller, MD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (04) : 841 - 847
  • [25] Progesterone, progestins and psychosomatic health of women
    Bitzer, Johannes
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2010, 3 (03) : 477 - 480
  • [26] Progesterone, progestins and the breast in menopause treatment
    Gompel, A.
    Plu-Bureau, G.
    CLIMACTERIC, 2018, 21 (04) : 326 - 332
  • [27] ROLE OF PROGESTERONE AND PROGESTINS IN HYDROELECTROLYTIC METABOLISM
    ELKIK, F
    MAUVAISJARVIS, P
    NOUVELLE PRESSE MEDICALE, 1980, 9 (01): : 35 - 38
  • [28] Progesterone and progestins: differential impact on CNS
    Pluchino, N.
    Russo, N.
    Genazzani, A. R.
    JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2010, 31 : 17 - 17
  • [29] NEUROENDOCRINE METABOLISM OF PROGESTERONE AND RELATED PROGESTINS
    KARAVOLAS, HJ
    HODGES, DR
    CIBA FOUNDATION SYMPOSIA, 1990, 153 : 22 - 55
  • [30] Therapeutic strategies for progesterone and progestins in pregnancy
    Schindler, AE
    HUMAN REPRODUCTION, 2005, : 285 - 290